Role of Human Papillomavirus in Tonsillar Cancer

  • Eva Munck-Wikland
  • Lalle Hammarstedt
  • Hanna Dahlstrand
Chapter
Part of the Methods of Cancer Diagnosis, Therapy and Prognosis book series (HAYAT, volume 7)

Abstract

Tonsillar cancer is the most common of the oropharyngeal malignancies and belongs to the group of head and neck cancer that originate in the Waldeyer’s ring. Smoking and alcohol are regarded as the main etiological factors for head and neck squamous cell carcinoma (HNSCC), but these tumors also occur in some 15-20% of patients without these risk factors. Accumulating data indicate that high risk human papillomavirus (HPV) is associated with a subgroup of HNSCC mainly oropharyngeal cancer (Gillison and Shah 2001; Mellin et al. 2000), and studies indicate that a history of smoking and high-risk HPV seropositivity, together, increase the risk for HNSCC suggesting that there is either an additive or synergistic relationship between these two risk factors.

References

  1. Begum S, Gillison ML, Nicol TL, Westra WH (2007) Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res 13:1186-1191PubMedCrossRefGoogle Scholar
  2. Braakhuis BJ, Snijders PJ, Keune WJ, Meijer CJ, Ruijter-Schippers HJ, Leemans CR, Brakenhoff RH (2004) Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 96:998-1006PubMedCrossRefGoogle Scholar
  3. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ (2002) GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40:779-787PubMedCrossRefGoogle Scholar
  4. Carter JJ, Madeleine MM, Shera K, Schwartz SM, Cushing-Haugen KL, Wipf GC, Porter P, Daling JR, McDougall JK, Galloway DA (2001) Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res 61:1934-1940PubMedGoogle Scholar
  5. Dahlgren L, Dahlstrand HM, Lindquist D, Hogmo A, Bjornestal L, Lindholm J, Lundberg B, Dalianis T, Munck-Wikland E (2004) Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer 112:1015-1019PubMedCrossRefGoogle Scholar
  6. Dahlgren L, Mellin H, Wangsa D, Heselmeyer-Haddad K, Bjornestal L, Lindholm J, Munck-Wikland E, Auer G, Ried T, Dalianis T (2003) Comparative genomic hybridization analysis of tonsillar cancr reveals a different patter of genomic imbalances in human papillomavirus-positive and -negative tumors. Int J Cancer 107:244-249PubMedCrossRefGoogle Scholar
  7. D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML (2007) Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356:1944-1956Google Scholar
  8. Gillison ML, Shah KV (2001) Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol 13:183-188PubMedCrossRefGoogle Scholar
  9. Gravitt PE, Kovacic MB, Herrero R, Schiffman M, Bratti C, Hildesheim A, Morales J (2007) High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int J Cancer 121:2787-2793PubMedCrossRefGoogle Scholar
  10. Hagmar B, Johansson B, Kalantari M, Petersson Z, Skyldberg B, Walaas L (1992) The incidence of HPV in a Swedish series of invasive cervical carcinoma. Med Oncol Tumor Pharmacother 9:113-117PubMedGoogle Scholar
  11. Hammarstedt L, Dahlstrand H, Lindquist D, Onelov L, Ryott M, Luo J, Dalianis T, Ye W, Munck-Wikland E (2007) The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol 127:988-992PubMedCrossRefGoogle Scholar
  12. Hammarstedt L, Lindquist D, Dahlstrand H, Romanitan M, Onelöv L (Dahlgren), Joneberg J, Creson N, Lindholm J, Ye W, Dalianis T, Munck-Wikland E (2006) Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 119:2620-2623Google Scholar
  13. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70PubMedCrossRefGoogle Scholar
  14. Hesselink AT, van den Brule AJ, Brink AA, Berkhof J, van Kemenade FJ, Verheijen RH, Snijders PJ (2004) Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples. Cancer 102:11-18PubMedCrossRefGoogle Scholar
  15. zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2:342-350PubMedCrossRefGoogle Scholar
  16. Kim SH, Koo BS, Kang S, Park K, Kim H, Lee KR, Lee MJ, Kim JM, Choi EC, Cho NH (2007) HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer 120:1418-1425PubMedCrossRefGoogle Scholar
  17. Kreimer AR, Alberg AJ, Daniel R, Gravitt PE, Viscidi R, Garrett ES, Shah KV, Gillison ML (2004) Oral human papillomavirus infection in adults is associated with sexual behaviour and HIV serostatus. J Infect Dis 189:686-698PubMedCrossRefGoogle Scholar
  18. Li Y, Nicols MA, Shay JW, Xiong Y (1994) Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 54:6078-6082PubMedGoogle Scholar
  19. Li W, Thompson CH, O’Brien CJ, McNeil EB, Scolyer RA, Cossart YE, Veness MJ, Walker DM, Morgan GJ, Rose BR (2003) Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer 106:553-558Google Scholar
  20. Li W, Tran N, Lee CS, O’Brien CJ, Tse GM, Scolyer RA, Hong A, Milross C, Yu KH, Rose BR (2007) New evidence for geographic variation in the role of human papillomavirus in tonsillar carcinogenesis. Pathology 39:217-222Google Scholar
  21. Lindquist D, Romanitan M, Hammarstedt L, Nasman A, Dahlstrand H, Lindholm J, Ramqvist T, Ye W, Munck-Wikland E, Dalianis T (2007) Human papillomavirus is a prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol 1(3):350-355Google Scholar
  22. Lungu O, Wright TC Jr, Silverstein S (1992) Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis. Mol Cell Probes 6:145-152PubMedCrossRefGoogle Scholar
  23. Mellin H, Dahlgren L, Munck-Wikland E, Lindholm J, Rabbani H, Kalantari M, Dalianis T (2002) Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 102:152-158PubMedCrossRefGoogle Scholar
  24. Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E (2000) Human papillomavirus DNA in tonsillar cancer: clinical correlates, risk of relapse and survival. Int J Cancer 89:300-304PubMedCrossRefGoogle Scholar
  25. Mellin Dahlstrand H, Lindquist D, Björnestål L, Ohlsson A, Dalianis T, Munck-Wikland E, Elmberger G (2005) P16 INK4a correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma. Anticancer Res 25:4375-4384PubMedGoogle Scholar
  26. Mork J, Lie K, Glattre E, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Sciller JT, Youngman L, Lehtinen M, Dillner J (2001) Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Eng J Med 344:1125-1131CrossRefGoogle Scholar
  27. Paavonen J, Jenkins D, Bosch FX, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter DL, Kitchener HC, Castellsague X, de Carvalho NS, Skinner SR, Harper DM, Hedrick JA, Jaisamrarn U, Limson GA, Dionne M, Quint W, Spiessens B, Peters P, Struyf F, Wieting SL, Lehtinen MO, Dubin G and HPV PATRICIA study group (2007) Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 369:2161-2170Google Scholar
  28. Pagliusi SR, Dillner J, Pawlita M, Quint WG, Wheeler CM, Ferguson M (2006) Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays - an update. Vaccine 24(Suppl 3):S193-200CrossRefGoogle Scholar
  29. Parry D, Bates S, Mann DJ, Peters G (1995) Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J 14:503-511PubMedGoogle Scholar
  30. Ragin CC, Taioli E (2007) Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 121:1813-1820PubMedCrossRefGoogle Scholar
  31. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ (1995) The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76:1057-1062PubMedCrossRefGoogle Scholar
  32. Rose RC, Bonnez W, Reichman RC, Garcea RL (1993) Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles. J Virol 67:1936-1944PubMedGoogle Scholar
  33. Smeets SJ, Braakhuis BJ, Abbas S, Snijders PJ, Ylstra B, van de Wiel MA, Meijer GA, Leemans CR, Brakenhoff RH (2006) Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene 25:2558-2564PubMedCrossRefGoogle Scholar
  34. Smeets SJ, Hasselink AT, Speel EJ, Haesevoets A, Snijders PJ, Pawlita M, Meijer CJ, Braakhuis BJ, Leemans CR, Brakenhoff RH (2007) A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 121:2465-2472PubMedCrossRefGoogle Scholar
  35. Smits HL, van Gemen B, Schukkink R, van der Velden J, Tjong-A-Hung SP, Jebbink MF, ter Schegget J (1995) Application of the NASBA nucleic acid amplification method for the detection of human papillomavirus type 16 E6-E7 transcripts. J Virol Methods 54:75-81PubMedCrossRefGoogle Scholar
  36. Sotlar K, Stubner A, Diemer D, Menton S, Menton M, Dietz K, Wallwiener D, Kandolf R, Bultmann B (2004) Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction. J Med Virol 74:107-116PubMedCrossRefGoogle Scholar
  37. Strome SE, Savva A, Brissett AE, Gostout BS, Lewis J, Clayton AC, McGovern R, Weaver AL, Persing D, Kasperbauer JL (2002) Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res 8:1093-1100PubMedGoogle Scholar
  38. Syrjanen K, Syrjanen S, Lamberg M, Pyrhönen S, Nuutinen J (1983) Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 12:418-424PubMedCrossRefGoogle Scholar
  39. Tieben LM, ter Schegget J, Minnaar RP, Bouwes Bavinck JN, Berkhout RJ, Vermeer BJ, Jebbink MF, Smits HL (1993) Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods 42:265-279PubMedCrossRefGoogle Scholar
  40. Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, Sasaki C, Joe J, Camp RL, Rimm DL, Psyrri A (2006) Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favourable prognosis. J Clin Oncol 24:736-747PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • Eva Munck-Wikland
    • 1
  • Lalle Hammarstedt
    • 1
  • Hanna Dahlstrand
    • 1
  1. 1.Department of Otorhinolaryngology Head and Neck SurgeryKarolinska University HospitalStockholmSweden

Personalised recommendations